The CEO of cannabis-tech startup Headset told us why having a concise mission statement is crucial to successfully pitching investors

The CEO ofHeadset, a data-analytics provider for the cannabis industry, revealed his key advice for making a successful pitch to potential investors. Cy Scott walked…

Read More The CEO of cannabis-tech startup Headset told us why having a concise mission statement is crucial to successfully pitching investors

Dispensed: The inside story of the Twitter outrage against CVS, a new marijuana breathalyzer, and a buzzy pharmacy startup

Hello, Healthcare reporterClarrie Feinstein here, writing the weekly newsletter whileLydia Ramsey continues her wonderful travels for her honeymoon! We’re definitely starting to miss her in…

Read More Dispensed: The inside story of the Twitter outrage against CVS, a new marijuana breathalyzer, and a buzzy pharmacy startup

Dispensed: The curious case of a viral hashtag, SmileDirectClub's IPO plans, and the 29 books to read if you want to disrupt healthcare

Hello, Just when you think you’re headed for a slow August news week… On Thursday,Emma Court spotted the hashtag #CVSDeniesCare going viral around Twitter. So…

Read More Dispensed: The curious case of a viral hashtag, SmileDirectClub's IPO plans, and the 29 books to read if you want to disrupt healthcare

Elizabeth Warren and Bernie Sanders just slammed the Swiss drug giant Novartis over a new controversy swirling around the world’s most expensive drug

Elizabeth Warren and Bernie Sanders are among a group of five senators who slammed Novartis’s AveXis for submitting manipulated data to the FDA ahead of…

Read More Elizabeth Warren and Bernie Sanders just slammed the Swiss drug giant Novartis over a new controversy swirling around the world’s most expensive drug

Dispensed: A big week for digital health IPOs, what happens when a $2.1 million drug can't get to the kids who need it, and what a top health-tech VC is looking to invest in

Hello, Welcome to Dispensed, Business Insider’s weekly newsletter bringing you all the stories that kept our healthcare team busy this week. WhileErin Brodwin’s been out…

Read More Dispensed: A big week for digital health IPOs, what happens when a $2.1 million drug can't get to the kids who need it, and what a top health-tech VC is looking to invest in

Bernie Sanders slams ‘polite f-u’ letters sent by generic drug companies as 'clearly illegal' and calls for an investigation

Business Insider reported exclusively last week that generic drug companies’ lawyers allegedly coordinated to send”‘polite f-u’ letters” in response to lawmakers’ inquiries about the spiking…

Read More Bernie Sanders slams ‘polite f-u’ letters sent by generic drug companies as 'clearly illegal' and calls for an investigation

We took the two-day, $1,300 'biotech for dummies' class where healthcare executives, HR managers, and investors catch up on science for the first time since high school

A $1,325, two-day class class called “Biotech for Non-Scientists” teaches executives, web designers, investors and others who work in or around the healthcare industry about…

Read More We took the two-day, $1,300 'biotech for dummies' class where healthcare executives, HR managers, and investors catch up on science for the first time since high school

Dispensed: CVS Health's plan to become a go-to spot for healthcare, uBiome's 75-person advisory boards, and an inside look at a massive generic drug lawsuit

Hello, Hope everyone is recovered from the long week of conferences! I wanted to start this week’s newsletter with a BIG welcome to Clarrie Feinstein,…

Read More Dispensed: CVS Health's plan to become a go-to spot for healthcare, uBiome's 75-person advisory boards, and an inside look at a massive generic drug lawsuit

Trading intel with rivals and searching for 'dirt': Inside the secret communications that allegedly show how big drug companies plotted for years to increase the price of your medicines

Attorneys general for 44 states recently brought anew lawsuit against the world’s largest generic drugmaker, Teva Pharmaceutical Industries, and 19 other generic drugmakers, alleging that…

Read More Trading intel with rivals and searching for 'dirt': Inside the secret communications that allegedly show how big drug companies plotted for years to increase the price of your medicines

We spoke with a key Merck executive about the strategy for its top cancer drug, a $7 billion powerhouse that could soon bring in more than $20 billion

Merck’s cancer drug Keytruda uses the body’s natural disease-fighting immune response to combat cancer. It has become apowerhouse for the company, bringing in $7 billion…

Read More We spoke with a key Merck executive about the strategy for its top cancer drug, a $7 billion powerhouse that could soon bring in more than $20 billion

A top executive at Swiss drug giant Novartis told us the inside story of the $2.1 million price tag for the most expensive drug in the world

The FDA just approved a cutting-edge new treatment from Swiss drug giant Novartis for a rare genetic disease called spinal muscular atrophy. Priced at $2.1…

Read More A top executive at Swiss drug giant Novartis told us the inside story of the $2.1 million price tag for the most expensive drug in the world

The doctor who helped create a skin-care line for Amazon just started a new website to take on drug companies that charge $2,000 for common creams

Costs areexploding for all kinds of drugs, including skin medications. Dermatologist Dr.Dhaval Bhanusali and his colleagues kept hearing from patients about these kinds of issues.…

Read More The doctor who helped create a skin-care line for Amazon just started a new website to take on drug companies that charge $2,000 for common creams

Dispensed: Tim Ferriss is backing psychedelic research, how to change your business model as told by pitch decks, and how much money healthcare CEOs make

Hello, Welcome to another edition of Dispensed, our newsletter recapping the stories that preoccupied Business Insider’s healthcare team this week. I’m told by a reader…

Read More Dispensed: Tim Ferriss is backing psychedelic research, how to change your business model as told by pitch decks, and how much money healthcare CEOs make

The CEO of pharmaceutical giant Merck is a Harvard-trained lawyer, and he shares what attorneys need to do to be 'treated as the wise people in the room' again

Lawyers today face a lot of pressure to specialize in a particular area of law. That emphasis comes at a price for the profession,Merck CEO…

Read More The CEO of pharmaceutical giant Merck is a Harvard-trained lawyer, and he shares what attorneys need to do to be 'treated as the wise people in the room' again